Pimoben Solo Tablet contains Pimobendan, a positive ionotropic agent that acts as a powerful cardiac stimulant. It is widely used in veterinary medicine for the management of congestive heart failure (CHF) and other chronic heart conditions in dogs. Pimobendan improves heart muscle contraction, reduces the heart’s workload, and enhances blood circulation, making it highly effective for dogs with heart disease.
Composition:
Pimobendan
Class: Ionotrope
Indications/Uses:
-
Management of congestive heart failure (CHF)
-
Treatment of dilated cardiomyopathy (DCM)
-
Support for atrioventricular valve insufficiency
-
Treatment of congestive heart failure associated with pre-existing systemic hypotension or acute renal failure
Benefits of Pimoben Solo Tablets:
-
Improves cardiac output and heart muscle efficiency
-
Reduces symptoms of heart failure such as coughing, lethargy, and breathing difficulty
-
Enhances exercise tolerance and overall quality of life in dogs
-
Provides reliable therapy for long-term heart support
Directions for Use:
-
Dosage: Administer Pimoben tablets orally at 12-hour intervals, 1 hour prior to food, or as recommended by your veterinarian
-
Net Quantity: 3 strips (10 tablets each)
-
Suitable For: Dogs
Disclosure:
A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the details of the pharmacy will be shared. Acceptance of your order depends on the validity of your doctor’s prescription and product availability.
Disclaimer:
Fifozone’s sole intention is to provide expert-reviewed, accurate, and trustworthy information. However, this content should not be used as a substitute for professional veterinary advice. The information provided is for educational purposes only and may not cover all aspects of health conditions, lab tests, medicines, side effects, drug interactions, or warnings. Always consult your veterinarian for personalized medical guidance. Fifozone aims to support, not replace, the veterinarian-patient relationship.

Reviews
There are no reviews yet.